Predictors of mucosal healing during induction therapy in patients with acute moderate‐to‐severe ulcerative colitis
- 14 December 2018
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 34 (6) , 1004-1010
Abstract
Background and Aim: The treat‐to‐target strategy has emerged in ulcerative colitis management. Mucosal healing is the best target, albeit not in induction therapy of acute diseases as clinical conditions vary over a short duration. To determine the targets during induction therapy for acute ulcerative colitis, we identified markers to predict mucosal healing at 3 and 12 months of initiating the induction therapy.Methods: This single‐center prospective observational study enrolling 61 adult patients hospitalized for disease exacerbation collected the partial Mayo scores, ulcerative colitis endoscopic index of severity, fecal markers, and laboratory data (0 day, 2 weeks, and 3 and 12 months) of initiating induction therapy.Results: At 2 weeks, patients with mucosal healing at 3 months had had lower partial Mayo and ulcerative colitis endoscopic index of severity scores and higher white blood cell count and total cholesterol than those without mucosal healing. At 3 months, patients with mucosal healing at 12 months had had lower partial Mayo and ulcerative colitis endoscopic index of severity scores than those without mucosal healing. A kinetic analysis demonstrated a difference in the partial Mayo scores and total cholesterol and albumin levels at 2 weeks and in the ulcerative colitis endoscopic index of severity, fecal calprotectin, and fecal immunochemical tests at 3 months between patients who achieved mucosal healing at 12 months and those who did not.Conclusions: Partial Mayo scores and total cholesterol levels act as short‐term therapeutic targets during induction therapy in patients with acute ulcerative colitis. Mucosal healing at 3 months correlates to longer time mucosal healing.Keywords
Funding Information
- Thermo Fisher Scientific
This publication has 28 references indexed in Scilit:
- Fecal Calprotectin Levels Predict the Clinical Course in Patients With New Onset of Ulcerative ColitisInflammatory Bowel Diseases, 2013
- Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)Gut, 2011
- Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative ColitisGastroenterology, 2011
- Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkersGut, 2010
- Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndromeGut, 2007
- Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second‐line medical therapy or surgeryAlimentary Pharmacology & Therapeutics, 2004
- Predicting outcome in severe ulcerative colitis.Gut, 1996
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- Assessment of severity in colitis: a preliminary study.Gut, 1975
- Cortisone in Ulcerative ColitisBMJ, 1955